Switch to
| Predicate | Object |
|---|---|
| rdf:type | |
| lifeskim:mentions | |
| pubmed:issue |
2
|
| pubmed:dateCreated |
1986-10-20
|
| pubmed:abstractText |
Twenty-eight patients admitted to hospital for alcohol withdrawal were treated with lofexidine, an alpha adrenergic agonist of the imidazole type, in an open trial. Twenty-three patients completed the regime. Symptoms were measured on a scale developed for the study: the Alcohol Withdrawal Rating Scale (AWRS). Scores on this scale fell steeply over three days, more slowly over the subsequent four--the period of the trial. Results are compatible with the hypothesis that alcohol withdrawal states are characterised by increased adrenergic activity.
|
| pubmed:language |
eng
|
| pubmed:journal | |
| pubmed:citationSubset |
IM
|
| pubmed:chemical | |
| pubmed:status |
MEDLINE
|
| pubmed:issn |
0735-0414
|
| pubmed:author | |
| pubmed:issnType |
Print
|
| pubmed:volume |
21
|
| pubmed:owner |
NLM
|
| pubmed:authorsComplete |
Y
|
| pubmed:pagination |
167-70
|
| pubmed:dateRevised |
2004-11-17
|
| pubmed:meshHeading |
pubmed-meshheading:3741551-Attention,
pubmed-meshheading:3741551-Blood Pressure,
pubmed-meshheading:3741551-Clonidine,
pubmed-meshheading:3741551-Ethanol,
pubmed-meshheading:3741551-Female,
pubmed-meshheading:3741551-Humans,
pubmed-meshheading:3741551-Male,
pubmed-meshheading:3741551-Substance Withdrawal Syndrome
|
| pubmed:year |
1986
|
| pubmed:articleTitle |
Lofexidine in alcohol withdrawal states.
|
| pubmed:publicationType |
Journal Article
|